The clinical rationale for obesity treatment extends beyond cosmetic benefit to meaningful cardiovascular risk reduction: Wegovy's label now includes cardiovascular risk reduction in overweight adults, fundamentally altering the value proposition for payers [1]
Bacterial diversity measured at the species level did not change significantly following liraglutide and GUB09-145 treatment, which indicates that drug treatment effects on gut microbiome signatures in DIO mice were attributed to re-arrangement of low-abundant species
Human data are somewhat more reassuring for accidental early exposure, but there is still not enough evidence to recommend continuing these medications throughout pregnancy
B12 is essential for various bodily functions, including energy production, red blood cell formation, and nerve health
As most patients with type 2 diabetes are treated in the primary-care setting, the increasing utilization of SGLT2 inhibitors and GLP1 agonists by our primary-care colleagues will improve outcomes in people with type 2 diabetes on a population level. The clinical guidelines cautioned against treating people with type 2 diabetes with inadequate glycemic control with dipeptidyl peptidase-4 (DPP-4) inhibitors, saying that high-certainty evidence showed that adding a DPP-4 inhibitor does not reduce morbidity or all-cause mortality.
Key Ingredients: Glutathione (100ppm):Potent antioxidant that brightens skin and reduces melanin production